OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of -12.50% and 5.10%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Corp. (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term....
OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 4.17% and 9.81%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Sea Limited's (SE) fourth-quarter 2022 results are likely to benefit from a stable Free Fire user base and the growing popularity of Shopee.
VMware (VMW) delivered earnings and revenue surprises of 7.58% and 2.16%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx (OPRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Oracle (ORCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avid (AVID) delivered earnings and revenue surprises of -4.26% and 1.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Corp. (OPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OptimizeRx Corp. (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term....